603456 九洲藥業
按盤價 
15.910 +1.450 (+10.028%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 5.636 | 15.020 | 18.659 | 16.550 | 12.820 |
| 總資產報酬率 ROA (%) | 4.323 | 11.012 | 12.320 | 10.528 | 7.870 |
| 投入資產回報率 ROIC (%) | 5.071 | 13.196 | 15.313 | 12.717 | 9.082 | 邊際利潤分析 |
| 銷售毛利率 (%) | 35.213 | 37.656 | 34.660 | 33.327 | 37.506 |
| 營業利潤率 (%) | 20.066 | 21.287 | 20.347 | 18.548 | 17.231 |
| 息稅前利潤/營業總收入 (%) | 18.350 | 20.006 | 18.689 | 19.244 | 20.457 |
| 淨利潤/營業總收入 (%) | 17.206 | 18.673 | 16.914 | 15.607 | 14.350 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 105.855 | 105.670 | 105.420 | 98.121 | 89.697 |
| 價值變動淨收益/利潤總額(%) | -0.960 | -1.640 | -3.003 | 8.013 | 9.104 |
| 營業外收支淨額/利潤總額(%) | 0.035 | 0.413 | -0.371 | -1.194 | -1.388 | 償債能力分析 |
| 流動比率 (X) | 3.308 | 3.812 | 1.804 | 1.809 | 1.406 |
| 速動比率 (X) | 2.356 | 2.629 | 0.891 | 1.003 | 0.689 |
| 資產負債率 (%) | 23.855 | 21.369 | 32.119 | 34.988 | 38.300 |
| 帶息債務/全部投入資本 (%) | 6.920 | 6.929 | 11.708 | 17.404 | -- |
| 股東權益/帶息債務 (%) | 1,297.912 | 1,301.104 | 720.957 | 456.889 | 312.252 |
| 股東權益/負債合計 (%) | 316.464 | 364.874 | 208.389 | 185.813 | 160.946 |
| 利息保障倍數 (X) | -10.654 | -14.610 | -11.810 | 21.023 | 5.908 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 75.198 | 53.230 | 47.541 | 62.786 | 0.000 |
| 存貨周轉天數 (天) | 190.751 | 208.092 | 187.365 | 189.485 | 0.000 |
| 備註： | 即時報價更新時間為 30/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
